Pfizer Inc logo

Pfizer Inc

€ 48.16 (+0.17%) Dec 6
P/E:
9.56
P/B:
3.01
Market Cap:
€ 265.83B ($ 279.37B)
Enterprise V:
€ 265.40B ($ 278.93B)
Volume:
250.00
Avg Vol (2M):
1.59K
Also Trade In:
Volume:
250.00
Market Cap €:
265.83B
Market Cap $:
279.37B
PE Ratio:
9.56
Avg Vol (2-Month):
1.59K
Enterprise Value €:
265.40B
Enterprise Value $:
278.93B
PB Ratio:
3.01
GF Score:
Year:
Not Enough Data to Display
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Not Enough Data to Display
Alerts Website Sources Stock Report
Dataset
Financial Download

Business Description

Description
Pfizer is one of the world's largest pharmaceutical firms, with annual sales close to $50 billion (excluding COVID-19 product sales). While it historically sold many types of healthcare products and chemicals, now, prescription drugs and vaccines account for the majority of sales. Top sellers include pneumococcal vaccine Prevnar 13, cancer drug Ibrance, cardiovascular treatment Eliquis, and immunology drug Xeljanz. Pfizer sells these products globally, with international sales representing close to 50% of its total sales. Within international sales, emerging markets are a major contributor.

Financials (Next Earnings Date:2023-02-08 Est.)

STU:PFE's 30-Y Financials

Guru Trades

See Details
To
Not Enough Data to Display

Insider Trades

See Details
To
Not Enough Data to Display

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
Not Enough Data to Display

Performance

Dividend
Log
To
Not Enough Data to Display

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Not Enough Data to Display

Valuation Box

Year:
Not Enough Data to Display

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 93,505.13
EPS (TTM) (€) 4.928
Beta 0.38
Volatility % 24.31
14-Day RSI 58.98
14-Day ATR (€) 0.6487
20-Day SMA (€) 47.272
12-1 Month Momentum % 3.8
52-Week Range (€) 39.1 - 54.5
Shares Outstanding (Mil) 5,613.31

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 8
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Pfizer Inc Filings

Document Form Filing Date
No Filing Data

Pfizer Inc Analysis

Share your research